The routine use of fresh frozen plasma in operations with cardiopulmonary bypass is not justified
- 31 July 1996
- journal article
- clinical trial
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 112 (1) , 162-167
- https://doi.org/10.1016/s0022-5223(96)70192-7
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The platelet function defect of cardiopulmonary bypass [see comments]Blood, 1993
- Perioperative haemotherapy: I. Indications for blood component transfusionCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1992
- Aprotinin prevents bleeding and has effects on platelets and fibrinolysisJournal of Cardiothoracic and Vascular Anesthesia, 1991
- The contribution of fibrinolysis to postbypass bleedingJournal of Cardiothoracic and Vascular Anesthesia, 1991
- Infectivity of blood seropositive for hepatitis C virus antibodiesThe Lancet, 1990
- Platelet preservation during cardiopulmonary bypass with aprotininEuropean Journal of Cardio-Thoracic Surgery, 1989
- Transfusion transmitted non‐A, non‐B hepatitisActa Anaesthesiologica Scandinavica, 1988
- Transfusion transmitted infectious agents, excluding hepatitis and human immunodeficiency virusesActa Anaesthesiologica Scandinavica, 1988
- Transfusion transmitted human T‐lymphotropic virus infectionsActa Anaesthesiologica Scandinavica, 1988
- Indications and Monitoring of Use of Fresh Frozen Plasma as a Hemostatic AgentPublished by S. Karger AG ,1985